Crossref
Assessing Antiaggregant, Anticoagulant, and Blood Product Transfusion Use in Patients Admitted to Intensive Care for Gastrointestinal Bleeding
Journal of Critical and Intensive Care · 2024
DOI: 10.14744/dcybd.2024.53394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Critical and Intensive Care, 2024. Verfasst von Kamil Gönderen.
Themen: Intensivpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gönderen, K. (2024). Assessing Antiaggregant, Anticoagulant, and Blood Product Transfusion Use in Patients Admitted to Intensive Care for Gastrointestinal Bleeding. Journal of Critical and Intensive Care. https://doi.org/10.14744/dcybd.2024.53394
Vancouver
Gönderen K. Assessing Antiaggregant, Anticoagulant, and Blood Product Transfusion Use in Patients Admitted to Intensive Care for Gastrointestinal Bleeding. Journal of Critical and Intensive Care. 2024. doi:10.14744/dcybd.2024.53394
BibTeX
@article{Gnderen2024,
author = {Gönderen, Kamil},
title = {Assessing Antiaggregant, Anticoagulant, and Blood Product Transfusion Use in Patients Admitted to Intensive Care for Gastrointestinal Bleeding},
journal = {Journal of Critical and Intensive Care},
year = {2024},
doi = {10.14744/dcybd.2024.53394}
}
EUVIMED